PRESS RELEASE

Munich, 18 May 2021

A team of honert led by partner Sven Fritsche and senior associate Dr. Kai-Klemens Wehlage provided comprehensive tax and legal advice to existing investor ATHOS KG in connection with a Series C financing round of AMSilk GmbH.

AMSilk GmbH, based in Planegg, is the world’s first industrial manufacturer of vegan silk biopolymers and produces sustainable products from biomaterials and is one of the world’s leading manufacturers of innovative high-performance biotech materials.

ATHOS KG is a family office of a German entrepreneurial family, which, among other things, invests directly in companies with a long-term and entrepreneurial orientation.
The volume of the Series C financing amounts to 29 million euros. In addition to the existing investors ATHOS KG and various MIG Funds, the new investors Novo Holdings, Cargill and E.R. Capital Holdings participated, whereby the fundraise was led by Novo Growth, a subsidiary of Novo Holdings.

Mr. Ulrich Scherbel, Chief Executive Officer of AMSilk, commented on the transaction: “Together with our customers, we work to create high-performance bio-based materials with the potential to revolutionize product offerings and drive change across various industries. It is exciting to have the support from high-technology investors, led by Novo Holdings, to make our silk polymers available in industrial quantities to an even broader range of customers and industries.”

Ms. Melissa Simon, on behalf of existing shareholder ATHOS KG, stated, “As original investors in the company, we have witnessed the immense progress achieved date and look forward to continuing to support AMSilk delivering on its vision.”

Consultants ATHOS KG:

honert (Munich): Sven Fritsche an Dr. Kai-Klemens Wehlage (both Venture Capital)

Consultants AMSilk GmbH and other existing shareholders

Lutz│Abel mbB

Consultants Novo:

Latham & Watkins LLP